Reaction

Extensor Plantar Response reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 916 reports · 21 co-occurring drugs

As of the last recalculation, Extensor Plantar Response appears in 916 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 39.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dimenhydrinate1839.139.2
Felodipine Extended-Release Tablets1938.738.8
Felodipine1938.738.7
Captopril1433.633.6
Phenytoin2528.028.0
Dextrose1424.524.5
Dextrose Monohydrate1424.224.2
Nebivolol1420.320.3
Fondaparinux Sodium719.819.8
Nitrofurantoin1318.218.2
Nitrofurantoin (Monohydrate/Macrocrystals)1317.917.9
Sumatriptan Succinate1917.417.4
Fingolimod Hcl6117.117.1
Prochlorperazine1815.015.0
Rifampicin613.613.6
Interferon Beta-1B1113.213.2
Nevirapine512.712.7
Efavirenz612.312.3
Rocuronium Bromide59.79.7
Sevoflurane38.28.2
Dalfampridine175.55.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.